Search clinical trials for: Drug interactions (Cytochrome P450 and p-glycoprotein)
Total 469818 results
-
Mutual Pharmaceutical Company, Inc.CompletedHealthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoproteinUnited States
-
Eisai Inc.Completed
-
National Institute on Alcohol Abuse and Alcoholism...SuspendedOverweight | Healthy VolunteersUnited States
-
Jules DesmeulesCompletedHealthy VolunteersSwitzerland
-
Karl Landsteiner Institute for Systematics in General...CompletedDisorder Due Cytochrome P450 CYP2D6 VariantAustria
-
National Institutes of Health Clinical Center (CC)CompletedHIV Infections | HealthyUnited States
-
H. Lundbeck A/SCompletedCytochrome P450 InteractionUnited Kingdom, United States
-
Advocate Health CareCompletedDelirium, Cytochrome P-450 Enzyme SystemUnited States
-
University of CologneUmm Al-Qura UniversityCompletedAOD Effects and ConsequencesGermany
-
Weill Medical College of Cornell UniversityCompletedKidney Failure, ChronicUnited States
-
Sumitomo Pharma America, Inc.CompletedDrug-drug InteractionsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedDepressive Disorder | Depression | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 VariantNetherlands
-
Columbia UniversityGlaxoSmithKline; American Epilepsy Society; Milken InstituteTerminatedEpilepsyUnited States
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
National Institute of Mental Health (NIMH)CompletedParkinson Disease | Alzheimer Disease | Frontotemporal Lobar DegenerationUnited States
-
University of UtahCubist Pharmaceuticals LLCCompletedPharmacokinetics | Drug InteractionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedAnovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 VariantGermany
-
AstraZenecaParexelCompletedHealthy ParticipantsUnited States
-
Royal Marsden NHS Foundation TrustUniversity of Brighton; Pharmacy Research UKUnknown
-
Hanmi Pharmaceutical Company LimitedCompletedHealthyKorea, Republic of
-
Washington University School of MedicineCompleted
-
Charite University, Berlin, GermanyUnknownObesity | Diabetes Mellitus, Type 1 | Healthy SubjectsGermany
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPoor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantBrazil
-
Boehringer IngelheimCompleted
-
National Cancer Institute (NCI)CompletedKidney Neoplasms | Neoplasm MetastasisUnited States
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Sony TutejaAmerican College of Clinical PharmacyCompletedKidney TransplantationUnited States
-
University Medical Center GroningenNot yet recruiting
-
CelgeneCompletedHealthy VolunteerUnited States
-
Dongyang LiuRecruitingHealth, Subjective | Nonvalvular Atrial FibrillationChina
-
National Institutes of Health Clinical Center (CC)National Institute of Allergy and Infectious Diseases (NIAID)Completed
-
National Institute of Mental Health (NIMH)Completed
-
AstraZenecaParexelTerminatedAdvanced Solid TumoursUnited States, Spain
-
National Institutes of Health Clinical Center (CC)Completed
-
Assistance Publique - Hôpitaux de ParisCompletedHealthy VolunteersFrance
-
CTI BioPharmaPPDCompletedDrug InteractionsUnited States
-
Bristol-Myers SquibbCompletedHealthy ParticipantsUnited States
-
University of GuadalajaraCompletedImpaired Glucose ToleranceMexico
-
Nutrition 21, Inc.CompletedEfficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DMDiabetes Mellitus, Type 2
-
Peking University Third HospitalRecruiting
-
Dongyang LiuRecruitingRespiratory Distress Syndrome of Newborn | Threatened Premature Labor, AntepartumChina
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
CelgeneCovanceCompletedHealthyUnited States
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel